MedTrace Logo

Creative Drama on Gender Role Stress, Attitudes Toward Violence Against Women, and Aggression

NCT07241156 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-04-09

No results posted yet for this study

Summary

This study aims to examine the effect of Creative Drama on gender role stress, attitudes toward violence against women, and aggression among men who experienced the February 6, 2023 earthquake in Türkiye (centered in Kahramanmaraş).

A total of 75 men (25 experimental, 25 placebo, and 25 control) will participate in the study. The experimental group will take part in a creative drama program, the placebo group will watch films focusing on masculinity roles and violence for 10 weeks, and no intervention will be applied to the control group.

Data will be collected using the Gender Role Stress Scale for Men, the Attitudes Toward Violence Against Women Scale, and the Buss-Perry Aggression Questionnaire - Short Form, and will be analyzed by an independent statistician.

The study aims to enhance the psychological well-being of men affected by the earthquake in Türkiye, reduce violence against women, and contribute to gender equality.

Conditions

  • Gender Role
  • Aggression
  • Violence

Interventions

BEHAVIORAL

Creative Drama Program

A structured 10-week Creative Drama program designed to reduce gender role stress, negative attitudes toward violence against women, and aggressive behaviors. Each session will include warm-up activities, improvisation, role-playing, and reflection components. Sessions will be conducted once a week for 90 minutes by a certified drama educator.

BEHAVIORAL

Film Viewing Sessions

Participants in the placebo group will watch 10 Turkish films over a 10-week period (one per week) that include themes of masculinity, gender roles, and violence. This intervention is designed as an attention-control condition to match the structure of the experimental group without providing therapeutic content.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Aslı SİS ÇELİK · Ataturk University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-30
Primary Completion
2026-04-30
Completion
2026-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07241156 on ClinicalTrials.gov